Zurich Cantonal Bank’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.29M | Buy |
114,340
+11,862
| +12% | +$134K | ﹤0.01% | 1100 |
|
2025
Q1 | $1.03M | Buy |
102,478
+9,357
| +10% | +$94.4K | ﹤0.01% | 1143 |
|
2024
Q4 | $1.1M | Buy |
93,121
+13,834
| +17% | +$164K | ﹤0.01% | 1137 |
|
2024
Q3 | $915K | Hold |
79,287
| – | – | ﹤0.01% | 1173 |
|
2024
Q2 | $838K | Buy |
79,287
+17,248
| +28% | +$182K | ﹤0.01% | 1164 |
|
2024
Q1 | $654K | Sell |
62,039
-1,697
| -3% | -$17.9K | ﹤0.01% | 1303 |
|
2023
Q4 | $716K | Sell |
63,736
-4,283
| -6% | -$48.1K | ﹤0.01% | 1258 |
|
2023
Q3 | $794K | Buy |
68,019
+5,465
| +9% | +$63.8K | ﹤0.01% | 1107 |
|
2023
Q2 | $631K | Buy |
62,554
+17,914
| +40% | +$181K | ﹤0.01% | 1219 |
|
2023
Q1 | $329K | Buy |
44,640
+4,010
| +10% | +$29.6K | ﹤0.01% | 1555 |
|
2022
Q4 | $325K | Buy |
40,630
+8,328
| +26% | +$66.5K | ﹤0.01% | 1515 |
|
2022
Q3 | $104K | Hold |
32,302
| – | – | ﹤0.01% | 2193 |
|
2022
Q2 | $131K | Buy |
+32,302
| New | +$131K | ﹤0.01% | 2051 |
|